Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to commercial, and drug substrate to final drug product of the CMOs, biotech, and pharma companies. Additional goals are to analyze the dynamics catalyzing growth, profile organizations presenting significant opportunities, and outline industry consolidation trends that will continue shaping the market. The base year of analysis is 2015 and forecasts run from 2016 to 2020.
Published: 16 Aug 2016

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Emerging Business Models Drive Transformation

The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to commercial, and drug substrate to final drug product of the CMOs, biotech, and pharma companies. Additional goals are to analyze the dynamics catalyzing growth, profile organizations presenting significant opportunities, and outline industry consolidation trends that will continue shaping the market. The base year of analysis is 2015 and forecasts run from 2016 to 2020.

Key Questions This Study Will Answer

  • Is the pharmaceutical CMO market growing, how long will it continue to grow, and at what rate?
  • What are the fastest growing segments of the pharmaceutical CMO market?
  • What growth opportunities exist in the pharmaceutical CMO industry?
  • What are the key drivers and restraints affecting the growth of CMOs?
  • What are the key challenges the CMOs are likely to face in the near and long-term? How can CMOs strategize to overcome these hurdles?
  • In what ways is the pharmaceutical CMO industry likely to change to meet industry trends and dynamics?
  • Who are the game-changing companies and what are the disruptive technologies and business models? How do CMOs position their assets with pharma companies?

Features of this Research

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..